Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial
BackgroundPrescription digital therapeutics are software-based disease treatments that are regulated by the US Food and Drug Administration; the reSET-O prescription digital therapeutic was authorized in 2018 and delivers behavioral treatment for individuals receiving bupreno...
Main Authors: | Hilary Luderer, Lisa Chiodo, Amanda Wilson, Christina Brezing, Suky Martinez, Xiaorui Xiong, Robert Gerwien, Bruce Imbert, Mark Deeg, Yuri Maricich, Aimee Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-01-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2022/1/e32759 |
Similar Items
-
A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study
by: Hilary Luderer, et al.
Published: (2023-01-01) -
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder
by: Velez FF, et al.
Published: (2021-10-01) -
Applications of technology in the assessment and treatment of cannabis use disorder
by: Christina A. Brezing, et al.
Published: (2022-10-01) -
The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory study
by: Suky Martinez, et al.
Published: (2022-12-01) -
Decentralization is Vulnerable Under the Gap Game
by: Yiran Liu, et al.
Published: (2019-01-01)